EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 48 filers reported holding EPIZYME INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $111,000 | -53.8% | 96,400 | +0.3% | 0.00% | – |
| Q4 2021 | $240,000 | -54.3% | 96,103 | -6.2% | 0.00% | – |
| Q3 2021 | $525,000 | -43.5% | 102,503 | -8.4% | 0.00% | – |
| Q2 2021 | $930,000 | -9.4% | 111,903 | -5.1% | 0.00% | – |
| Q1 2021 | $1,027,000 | -31.2% | 117,904 | -14.3% | 0.00% | -100.0% |
| Q4 2020 | $1,493,000 | -9.0% | 137,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,640,000 | -27.3% | 137,500 | -2.1% | 0.00% | 0.0% |
| Q2 2020 | $2,255,000 | +36.7% | 140,400 | +32.0% | 0.00% | 0.0% |
| Q1 2020 | $1,650,000 | -37.8% | 106,400 | -1.4% | 0.00% | -50.0% |
| Q4 2019 | $2,654,000 | +138.5% | 107,900 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $1,113,000 | -17.8% | 107,900 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,354,000 | +38.2% | 107,900 | +36.4% | 0.00% | 0.0% |
| Q1 2019 | $980,000 | +101.2% | 79,100 | 0.0% | 0.00% | – |
| Q4 2018 | $487,000 | -41.5% | 79,100 | +0.6% | 0.00% | -100.0% |
| Q3 2018 | $833,000 | -21.8% | 78,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,065,000 | +9.9% | 78,600 | +44.0% | 0.00% | 0.0% |
| Q1 2018 | $969,000 | +102.3% | 54,600 | +42.9% | 0.00% | – |
| Q4 2017 | $479,000 | -40.7% | 38,200 | -9.9% | 0.00% | -100.0% |
| Q3 2017 | $808,000 | +40.8% | 42,400 | +11.6% | 0.00% | – |
| Q2 2017 | $574,000 | -12.0% | 38,000 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $652,000 | +29.1% | 38,000 | -8.9% | 0.00% | – |
| Q4 2016 | $505,000 | +23.2% | 41,700 | 0.0% | 0.00% | – |
| Q3 2016 | $410,000 | -1.4% | 41,700 | +2.7% | 0.00% | – |
| Q2 2016 | $416,000 | +21.3% | 40,600 | +43.5% | 0.00% | – |
| Q1 2016 | $343,000 | -51.9% | 28,300 | -36.4% | 0.00% | -100.0% |
| Q4 2015 | $713,000 | +19.4% | 44,500 | -4.2% | 0.00% | 0.0% |
| Q3 2015 | $597,000 | -45.0% | 46,430 | +2.7% | 0.00% | 0.0% |
| Q2 2015 | $1,085,000 | +298.9% | 45,200 | +211.7% | 0.00% | – |
| Q1 2015 | $272,000 | -1.8% | 14,500 | -1.4% | 0.00% | – |
| Q4 2014 | $277,000 | -38.9% | 14,700 | -12.0% | 0.00% | – |
| Q3 2014 | $453,000 | +18.3% | 16,700 | +35.8% | 0.00% | – |
| Q2 2014 | $383,000 | +37.3% | 12,300 | +0.5% | 0.00% | – |
| Q1 2014 | $279,000 | +9.4% | 12,237 | 0.0% | 0.00% | – |
| Q4 2013 | $255,000 | -65.7% | 12,237 | -34.0% | 0.00% | -100.0% |
| Q3 2013 | $744,000 | +485.8% | 18,537 | +311.1% | 0.00% | – |
| Q2 2013 | $127,000 | – | 4,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |